Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-12 | Zentalis Pharmaceuticals, Inc. | Epperly Melissa B,
(Chief Financial Officer) |
S | Common Stock | D | 2573 | $11.44 - $11.44 | $29,435 |
| 2024-02-12 | Zentalis Pharmaceuticals, Inc. | Gallagher Cam
(President) |
S | Common Stock | D | 1173 | $11.44 - $11.44 | $13,419 |
| 2024-02-01 | Zentalis Pharmaceuticals, Inc. | HAUSMAN DIANA
(Chief Medical Officer) |
A | Common Stock | A | 337500 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Zentalis Pharmaceuticals, Inc. | Lackner Mark
(Chief Scientific Officer) |
S | Common Stock | D | 1585 | $11.54 - $11.54 | $18,290 |
| 2024-02-01 | Zentalis Pharmaceuticals, Inc. | Lackner Mark
(Chief Scientific Officer) |
A | Common Stock | A | 141000 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Zentalis Pharmaceuticals, Inc. | Paul Andrea
(Chief Legal Officer) |
S | Common Stock | D | 3310 | $11.54 - $11.54 | $38,197 |
| 2024-02-01 | Zentalis Pharmaceuticals, Inc. | Paul Andrea
(Chief Legal Officer) |
A | Common Stock | A | 112500 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Zentalis Pharmaceuticals, Inc. | Gallagher Cam
(President) |
S | Common Stock | D | 11552 | $11.54 - $11.54 | $133,310 |
| 2024-02-01 | Zentalis Pharmaceuticals, Inc. | Gallagher Cam
(President) |
A | Common Stock | A | 192500 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Zentalis Pharmaceuticals, Inc. | Epperly Melissa B,
(Chief Financial Officer) |
S | Common Stock | D | 8669 | $11.54 - $11.54 | $100,040 |
| 2024-02-01 | Zentalis Pharmaceuticals, Inc. | Epperly Melissa B,
(Chief Financial Officer) |
A | Common Stock | A | 75000 | $0.00 - $0.00 | $0 |
| 2024-02-01 | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly
(Chief Executive Officer) |
F | Common Stock | D | 20655 | $11.69 - $11.69 | $241,456 |
| 2024-02-01 | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly
(Chief Executive Officer) |
A | Common Stock | A | 250000 | $0.00 - $0.00 | $0 |
| 2024-01-02 | Zentalis Pharmaceuticals, Inc. | Lackner Mark
(Chief Scientific Officer) |
A | Common Stock | A | 40000 | $0.00 - $0.00 | $0 |
| 2023-12-20 | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D.
(Chief Scientific Officer) |
G | Common Stock | D | 24158 | $0.00 - $0.00 | $0 |
| 2023-11-10 | Zentalis Pharmaceuticals, Inc. | Johnson David Mic...
(Director) |
P | Common Stock | A | 17000 | $9.88 - $9.88 | $167,943 |
| 2023-11-13 | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly
(Chief Executive Officer) |
P | Common Stock | A | 5000 | $10.29 - $10.29 | $51,448 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |